Impact of surface-guided positioning on the use of portal imaging and initial set-up duration in breast cancer patients.

Einfluss der Patientenpositionierung mittels optischem Oberflächenscanner auf die Verwendung von Verifikationsaufnahmen und die Dauer der Neueinstellung bei Brustkrebspatientinnen.

Journal

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
ISSN: 1439-099X
Titre abrégé: Strahlenther Onkol
Pays: Germany
ID NLM: 8603469

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 13 05 2019
accepted: 27 06 2019
pubmed: 25 7 2019
medline: 20 3 2020
entrez: 24 7 2019
Statut: ppublish

Résumé

The impact of optical surface guidance on the use of portal imaging and the initial set-up duration in patients receiving postoperative radiotherapy of the breast or chest wall was investigated. A retrospective analysis was performed including breast cancer patients who received postoperative radiotherapy between January 2016 and December 2016. One group of patients received treatment before the optical surface scanner was installed (no-OSS) and the other group was positioned using the additional information derived by the optical surface scanner (OSS). The duration of the initial set-up was recorded for each patient and a comparison of both groups was performed. Accordingly, the differences between planned and actually acquired portal images during the course of radiotherapy were compared between both groups. A total of 180 breast cancer patients were included (90 no-OSS, 90 OSS) in this analysis. Of these, 30 patients with left-sided breast cancer received radiotherapy in deep inspiration breath hold (DIBH). The mean set-up time was 10 min and 18 s and no significant difference between the two groups of patients was found (p = 0.931). The mean set-up time in patients treated without DIBH was 9 min and 45 s compared to 13 min with DIBH (p < 0.001), as portal imaging was performed in DIBH. No significant difference was found in the number of acquired to the planned number of portal images during the entire radiotherapy treatment for both groups (p = 0.287). Optical surface imaging is a valuable addition for primary patient set-up. The findings confirm that the addition of surface-based imaging did not prolong the clinical workflow and had no significant impact on the number of portal verification images carried out during the course of radiotherapy.

Identifiants

pubmed: 31332457
doi: 10.1007/s00066-019-01494-x
pii: 10.1007/s00066-019-01494-x
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

964-971

Références

Strahlenther Onkol. 2013 Oct;189(10):887-93
pubmed: 23740155
Strahlenther Onkol. 2013 Nov;189(11):938-44
pubmed: 24068172
Rep Pract Oncol Radiother. 2018 Jan-Feb;23(1):61-67
pubmed: 29379398
Radiat Oncol. 2016 Oct 26;11(1):143
pubmed: 27784326
Strahlenther Onkol. 2018 Sep;194(9):797-805
pubmed: 29974132
Strahlenther Onkol. 2012 Dec;188(12):1080-4
pubmed: 23138774
Pract Radiat Oncol. 2016 Nov - Dec;6(6):e235-e241
pubmed: 27025165
Strahlenther Onkol. 2019 Jan;195(1):13-20
pubmed: 30143814
Radiother Oncol. 2017 Jan;122(1):2-10
pubmed: 27641786
Radiat Oncol. 2016 Nov 24;11(1):154
pubmed: 27881158
Technol Cancer Res Treat. 2012 Feb;11(1):57-68
pubmed: 22181332
Radiat Oncol. 2018 Jul 16;13(1):128
pubmed: 30012156
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818806002
pubmed: 30453842
Semin Radiat Oncol. 2018 Jun;28(3):185-193
pubmed: 29933878
Radiat Oncol. 2015 Mar 19;10:68
pubmed: 25881018
Pract Radiat Oncol. 2013 Jan-Mar;3(1):16-25
pubmed: 24674259
Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):536-42
pubmed: 22652107
Strahlenther Onkol. 2019 Jan;195(1):1-12
pubmed: 30310926

Auteurs

Montserrat Pazos (M)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.

Franziska Walter (F)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany. franziska.walter@med.uni-muenchen.de.

Daniel Reitz (D)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.

Stephan Schönecker (S)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.

Dinah Konnerth (D)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.

Annemarie Schäfer (A)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.

Maya Rottler (M)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.

Filippo Alongi (F)

Advanced Radiation Oncology Department, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar-Verona, Italy.
University of Brescia, Brescia, Italy.

Philipp Freislederer (P)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.

Maximilian Niyazi (M)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.

Claus Belka (C)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.

Stefanie Corradini (S)

Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH